Archive Newsletter

31. 11.19.25 -- Optimize Formulation And Integrity Workflows 11/19/2025

    11/19/25 Cell & Gene Newsletter

32. 11.19.25 -- Navigating Regulatory Frameworks For Allogeneic CAR-NK Control Strategies 11/19/2025
    11/19/25 Cell & Gene Newsletter
33. 11.18.25 -- STREAM Edition: Advancing Hematology And Cell Therapy Innovation 11/18/2025

    11/18/25 Cell & Gene Newsletter

34. 11.18.25 -- What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma? 11/18/2025
    11/18/25 Cell & Gene Newsletter
35. 11.17.25 -- Streamline Your Workflow With Single-Use 2L Bioprocess Bags 11/17/2025

    11/17/25 Cell & Gene Newsletter

36. 11.17.25 -- The Latest On Cell & Gene CDMO Capabilities And Capacity 11/17/2025
    11/17/25 Cell & Gene Newsletter
37. 11.17.25 -- Are You Still Evaluating CMOs When You Really Need A CDMO? 11/17/2025
    11/17/25 Cell & Gene Newsletter
38. 11.14.25 -- Overcoming Roadblocks To Advanced Therapy Manufacture 11/14/2025

    11/14/25 Cell & Gene Newsletter

39. 11.14.25 -- Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/14/2025
    11/14/25 Cell & Gene Newsletter
40. 11.13.25 -- Controlling Critical Quality Attributes In RNA Manufacturing 11/13/2025

    11/13/25 Cell & Gene Newsletter